• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Citic Private Equity

china-compass-navigation-risk-business
China: Who’s investing?

Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles

  • Greater China
  • 03 May 2023
skin-care-face-treatment
China's Giant Biogene trades up after $70m Hong Kong IPO

Giant Biogene, a China-based producer of skin treatments that use bioactive ingredients, gained nearly 10% on debut following a HKD 549.4m (USD 70m) Hong Kong IPO.

  • Greater China
  • 08 November 2022
imab-biotech-drug-healthcare
CPE joins Series D for China biotech player TransThera

TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.

  • Greater China
  • 27 July 2021
Boyu stands out in weak quarter for private equity fundraising

A quickfire fundraise by Boyu Capital – which saw $6 billion collected across two pools of capital in the space of a few months – accounted for more than one-quarter of all capital committed to Asia-focused private equity managers between April and...

  • Greater China
  • 15 July 2021
hair-thin
China hair transplant business files for Hong Kong IPO

Yonghe Medical Group, a Chinese hair healthcare specialist best known for hair transplants, is targeting a Hong Kong IPO. Its largest external shareholder is CPE, formerly CITIC Private Equity.

  • Greater China
  • 18 June 2021
oatly-ipo
China-backed Oatly raises $1.4b in US IPO

Oatly, a Swedish oat-based, dairy-free beverage brand backed by a joint venture between China Resources Group and Verlinvest, raised $1.43 billion in its US IPO, facilitating partial exits for several investors.

  • Greater China
  • 22 May 2021
weilong
China snack maker Weilong raises $549m, pursues HK IPO

China’s leading spicy snack food company Weilong has raised a $549 million pre-IPO round at a valuation of $9.4 billion and filed for a Hong Kong IPO.

  • Greater China
  • 17 May 2021
truck-logistics-transportation
China's ANE Logistics files for Hong Kong IPO

ANE Logistics, a Chinese road freight transportation business backed by Centurium Capital, CDH Investments, and CPE among others, has filed for a Hong Kong IPO.

  • Greater China
  • 10 May 2021
cybersecurity-4
China's NextData raises $135m Series D

NextData, a China-based cybersecurity services provider, has secured $135 million in Series D funding led by CPE, Matrix China Partners, Hopu Investment, Tencent Holdings, and Xiang He Capital.

  • Greater China
  • 22 April 2021
oatly
China-backed Oatly pursues US IPO

Oatly, a Swedish oat-based, dairy-free beverage brand backed by a joint venture between China Resources Group and Verlinvest, has filed for a US IPO and put in place a mechanism for an additional Hong Kong listing.

  • Greater China
  • 21 April 2021
dollar-bill-money
CPE hits $1.8b first close on China fund

CPE has reached a first close of $1.8 billion on its fourth US dollar-denominated fund following a six-month period punctuated by three new investments and four portfolio company IPOs.

  • Greater China
  • 19 April 2021
cybersecurity-6
China cybersecurity player ThreatBook raises $77m

Beijing-based cybersecurity solutions provider ThreatBook has completed a RMB500 million ($77 million) Series E round led by CPE and featuring existing investor V Fund.

  • Greater China
  • 22 March 2021
hospital-surgery-nurse
Deal focus: CPE backs MicroPort's medical devices agenda

CPE has backed a string of spinouts from Chinese medical device manufacturer MicroPort Medical. MicroPort CardioFlow Medtech’s Hong Kong IPO represents its first liquidity event

  • Greater China
  • 11 February 2021
pony-ai-car-autonomous
Brunei, CPE join Series C extension for China's Pony.ai

Chinese autonomous driving technology supplier Pony.ai has secured a Series C extension of $100 million featuring new investors Brunei Investment Agency and CPE. It takes the company’s total funding to date past $1.1 billion.

  • Greater China
  • 09 February 2021
artificial-intelligence-facial-recognition-4
China AI specialist 4Paradigm receives $700m Series D

Boyu Capital, Primavera Capital Group, and Hopu Investments have led a $700 million Series D round for 4Paradigm, a Chinese artificial intelligence (AI) technology developer that serves enterprise customers.

  • Greater China
  • 25 January 2021
smart-car-autonomous-driving-01
China's Horizon Robotics raises $400m

Horizon Robotics, a Chinese developer of microprocessors that support artificial intelligence (AI) technologies, has raised $400 million in the second tranche of a Series C round led by Baillie Gifford, Yunfeng Capital, CPE, and electric vehicle battery...

  • Greater China
  • 08 January 2021
artificial-intelligence-ai-chip
China AI chip player Enflame raises $279m Series C

Enflame Technology, a Chinese artificial intelligence (AI) chip designer, has raised a RMB1.8 billion ($279 million) Series C round led by CPE, China Capital Investment Group, and Primavera Capital.

  • Greater China
  • 06 January 2021
DCP, CPE make $300m China data center play

DCP Capital Partners and CPE – formerly CITIC Private Equity – have led a $300 million investment in Hotwon Group, a Chinese cloud computing infrastructure services provider.

  • Greater China
  • 17 December 2020
JD Health targets largest Chinese PE-backed IPO in two years

JD Health, a Chinese online-to-offline healthcare business that raised around $1.9 billion from private investors after it spun out from JD.com, is looking to raise HK$26.9 billion ($3.48 billion) in its Hong Kong IPO.

  • Greater China
  • 27 November 2020
car-t-cell
China's JW Therapeutics trades up after $300m Hong Kong IPO

JW Therapeutics, a private equity-backed Chinese drug developer specializing in CAR T-cell therapies that engineer immune cells to fight cancers, has raised HK$2.33 billion ($300 million) through a Hong Kong IPO.

  • Greater China
  • 05 November 2020
PE-backed JD Health files for Hong Kong IPO

JD Health, the healthcare unit of Chinese e-commerce giant JD.com, has filed for Hong Kong IPO. The company’s backers include Hillhouse Capital, CPE, CICC Capital, and Baring Private Equity Asia.

  • Greater China
  • 01 October 2020
China medical device player Hanyu Medical secures $72m

China-based medical devices manufacturer Hanyu Medical has raised a RMB500 million ($72 million) Series D co-led by HighLight Capital, CPE (formerly known as CITIC Private Equity), and Yingke Private Equity.

  • Greater China
  • 17 August 2020
CPE, GDS team up on China data center project

CPE - formerly CITIC Private Equity - and GDS Holdings have jointly acquired a greenfield data center project in China that will represent a RMB2.6 billion ($371 million) investment upon completion.

  • Greater China
  • 24 July 2020
CPE, Mirae lead $100m Series B for China's JW Therapeutics

JW Therapeutics, a China cancer treatment specialist established by Bristol Myers Squibb-owned Juno Therapeutics and China’s WuXi AppTec, has received $100 million in Series B funding.

  • Greater China
  • 11 June 2020
1 2 3
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013